Filing Details

Accession Number:
0001264124-12-000056
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-24 17:02:02
Reporting Period:
2012-02-22
Filing Date:
2012-02-24
Accepted Time:
2012-02-24 17:02:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881464 Amylin Pharmaceuticals Inc AMLN Pharmaceutical Preparations (2834) 330266089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236389 G Mark Foletta 9360 Towne Centre Dr
San Diego CA 92121
Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-22 15,000 $0.00 69,077 No 4 A Direct
Common Stock Disposition 2012-02-23 5,638 $17.03 63,439 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,868 Indirect Indirect-401k
Common Stock 6,445 Indirect by ESOP
Common Stock 110 Indirect by wife
Footnotes
  1. Represents shares acquired upon vesting of performance-based restricted stock units.
  2. Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units.
  3. These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
  4. The reporting person acquired beneficial ownership of these shares in November, 2007.